TAK
Takeda Pharmaceutical Co Ltd ADRNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$50.27B
P/E Ratio
43.00
EPS
$0.37
Beta
0.09
52W High
$18.90
52W Low
$12.78
50-Day MA
$16.68
200-Day MA
$16.00
Dividend Yield
4.16%
Profit Margin
4.26%
Forward P/E
10.17
PEG Ratio
0.40
About Takeda Pharmaceutical Co Ltd ADR
Takeda Pharmaceutical Company Limited is engaged in the research, development, manufacture and marketing of pharmaceuticals, over-the-counter drugs and quasi-drug consumer products, and other health care products. The company is headquartered in Tokyo, Japan.
Fundamentals
| Revenue (TTM) | $4.51T |
| Gross Profit (TTM) | $2.93T |
| EBITDA | $1.35T |
| Operating Margin | 3.09% |
| Return on Equity | 2.61% |
| Return on Assets | 2.63% |
| Revenue/Share (TTM) | $1430.33 |
| Book Value | $15.34 |
| Price-to-Book | 1.03 |
| Price-to-Sales (TTM) | 0.01 |
| EV/Revenue | 2.707 |
| EV/EBITDA | 9.11 |
| Quarterly Earnings Growth (YoY) | 330.20% |
| Quarterly Revenue Growth (YoY) | 3.90% |
| Shares Outstanding | $3.16B |
| Float | $3.16B |
| % Insiders | 0.02% |
| % Institutions | 3.14% |
Historical Volatility
HV 10-Day
31.91%
HV 20-Day
25.57%
HV 30-Day
21.77%
HV 60-Day
22.12%
HV Rank
72.2%
Volatility is currently expanding
Analyst Ratings
Consensus ($20.69 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026